Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Claudio

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Anticancer Research|January 1, 1997
Role of PCNA in differentiating between malignant mesothelioma and mesothelial hyperplasia: prognostic considerationsV Esposito, A Baldi, A De Luca, et al.
The Journal of Clinical Investigation|February 14, 1998
Activated Raf-1 causes growth arrest in human small cell lung cancer cellsR K Ravi, E Weber, M McMahon, et al.
Circulation Research|November 26, 1999
Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplastyP P Claudio, L Fratta, F Farina, et al.
Journal of Cellular Physiology|September 27, 2001
pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleusN Zini, C Trimarchi, P P Claudio, et al.
The American Journal of Pathology|March 7, 2000
Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypesC Cinti, L Leoncini, A Nyongo, et al.
Oncogene|October 24, 2000
A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell lineC Cinti, P P Claudio, A D Luca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth controlL Leoncini, C Bellan, A Cossu, et al.
Cancer Research|February 24, 2001
RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivoP P Claudio, P Stiegler, C M Howard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2009
Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approachAdelaide Greco, Altomare Di Benedetto, Candace M Howard, et al.
Cancer Research|February 10, 2000
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transferP P Claudio, C M Howard, C Pacilio, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Anticancer Research|January 1, 1997
Role of PCNA in differentiating between malignant mesothelioma and mesothelial hyperplasia: prognostic considerationsV Esposito, A Baldi, A De Luca, et al.
The Journal of Clinical Investigation|February 14, 1998
Activated Raf-1 causes growth arrest in human small cell lung cancer cellsR K Ravi, E Weber, M McMahon, et al.
Circulation Research|November 26, 1999
Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplastyP P Claudio, L Fratta, F Farina, et al.
Journal of Cellular Physiology|September 27, 2001
pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleusN Zini, C Trimarchi, P P Claudio, et al.
The American Journal of Pathology|March 7, 2000
Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypesC Cinti, L Leoncini, A Nyongo, et al.
Oncogene|October 24, 2000
A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell lineC Cinti, P P Claudio, A D Luca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth controlL Leoncini, C Bellan, A Cossu, et al.
Cancer Research|February 24, 2001
RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivoP P Claudio, P Stiegler, C M Howard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2009
Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approachAdelaide Greco, Altomare Di Benedetto, Candace M Howard, et al.
Cancer Research|February 10, 2000
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transferP P Claudio, C M Howard, C Pacilio, et al.
Pageof 6